Management of Significant Proteinuria Detected by Urine Dipstick

Confirmatory Quantitative Testing

When a dipstick shows large proteinuria (≥2+ or 3+), obtain quantitative confirmation with a spot urine protein‑to‑creatinine ratio (PCr) or a 24‑hour urine collection, because the dipstick is only semi‑quantitative and prone to false results. [@1]
The spot urine PCr is the preferred confirmatory test; it is more practical than a 24‑hour collection while providing comparable diagnostic accuracy. [@1]
A PCr ≥ 30 mg/mmol (≈0.3 mg/mg) defines abnormal proteinuria. [@1]
A 24‑hour urine collection showing ≥ 300 mg protein/day remains the gold‑standard definition of proteinuria. [@1]

Moderate proteinuria (300 mg–5 g/24 h) in non‑pregnant adults indicates chronic kidney disease (CKD) and warrants evaluation for an underlying cause. [@5]
Massive proteinuria (>5 g/24 h or PCr > 900 mg/mmol) in pregnancy is linked to more severe neonatal outcomes and earlier delivery. [@3]
In patients > 35 years, a PCr > 500 mg/mmol correlates with poorer maternal outcomes during pregnancy. [@2]

New‑onset proteinuria after 20 weeks gestation raises suspicion for preeclampsia, even if blood pressure is not yet elevated. [@2]
In women with chronic hypertension, any new or worsening proteinuria suggests superimposed preeclampsia. [@2]
Delivery decisions should not be based solely on the degree of proteinuria; severity of hypertension and evidence of end‑organ damage are more predictive of adverse outcomes. [@2]

Immediate blood‑pressure measurement is essential, because the combination of hypertension and proteinuria markedly changes management. [@1]
In diabetic individuals, urinary albumin‑to‑creatinine ratio (UACR) should be measured rather than total protein; persistent albuminuria is defined by ≥ 2 of 3 samples with UACR > 30 mg/g. [@5]

Serum creatinine and estimated glomerular filtration rate (eGFR) must be obtained to stage CKD. [@4]
When eGFR is 45–59 mL/min/1.73 m² without other markers of kidney damage, cystatin C measurement can be considered to confirm CKD. [@4]

Patients with higher proteinuria levels and lower eGFR require more frequent monitoring—up to four times per year for severe disease. [@4]
Repeat quantitative testing whenever dipstick results change or the clinical situation evolves. [@2]
Small fluctuations in proteinuria are common and do not necessarily indicate disease progression. [@4]

Initiate thromboprophylaxis when nephrotic‑range proteinuria is confirmed, because this state carries an increased risk of thrombotic events. [@1]

Do not rely on dipstick alone for management decisions; its semi‑quantitative nature and urine‑concentration dependence limit reliability. (Supported by multiple guideline statements.)
Do not assume a negative dipstick excludes significant proteinuria in high‑risk patients; false‑negative results occur, especially in dilute urine. [@1]
Do not use the term “microalbuminuria” in reports; current guidelines recommend reporting the actual albumin‑to‑creatinine ratio with defined risk categories. [@4]